Frequent alterations of the p14ARF and p16INK4a genes in primary central nervous system lymphomas

Cancer Research

Volumn 61, Issue 17, 2001, Pages 6335-6339

  Nakamura, M ^a   Sakaki, T ^a   Hashimoto, H ^a   Nakase, H ^a   Ishida, E ^a   Shimada, K ^a   Konishi, N ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P14; PROTEIN P16; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; CENTRAL NERVOUS SYSTEM TUMOR; CONTROLLED STUDY; CPG ISLAND; DELETION MUTANT; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOMA; METHYLATION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

CELL CYCLE PROTEINS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; DNA METHYLATION; GENE DELETION; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN BIOSYNTHESIS; PROTEINS; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEINS;

EID: 0035417926     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome
2. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
3. Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL
4. Frequent deletion and 5′ CpG island methylation of the p16 gene in primary malignant lymphoma of the brain
5. Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
6. ARF, participates in a regulatory, feedback loop with p53 and MDM2
7. ARF deletion and methylation in genetic pathways to glioblastomas
8. INK4A, MTSI) and CDK4 genes have frequent mutations of the retinoblastoma gene
9. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene
10. INK4a methylation and p53 mutational status
11. INK4a genes in human esophageal squamous cell carcinoma
12. INK4a (MTSI) in B-cell and T-cell lymphomas
13. Altered expression of the retinoblastoma gene product in human high grade non-Hodgkin's lymphomas
14. Promoter hypermethylation of the RBI gene in glioblastomas
15. Methylation-specific PCR a novel PCR assay for methylation status of CpG islands
16. Loss of pRb expression in pituitary adenomas is associated with methylation of the RBI CpG island
17. Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma
18. ARF promoter CpG island and its methylation pattern in primary lymphomas
19. Tumor spectrum in ARF-deficient mice
20. Overexpression of the MDM2 gene is found in some cases of haematological malignancies
21. Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma
22. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas
23. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis
24. Waf1 genes are associated with aggressive variants of mantle cell lymphomas
25. Absence of somatic changes in p21 gene in non-Hodgkin's lymphoma and chronic myelogenous leukemia
26. Absence of WAF1 mutations in a variety of human malignancies
27. KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma
28. Kip1 promoter methylation in malignant melanoma
29. Kip1 accumulation during the cell cycle